N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
US7053089B2 · kind B2 · utility
6Cited by
8References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 20, 2002 |
| Grant date | May 30, 2006 |
| Priority date | — |
| Expiry date | Jun 3, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D475/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds represented by Formula (I):or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for relieving pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.